1. Home
  2. NTLA vs TH Comparison

NTLA vs TH Comparison

Compare NTLA & TH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$16.51

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$18.26

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTLA
TH
Founded
2014
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
NTLA
TH
Price
$16.51
$18.26
Analyst Decision
Buy
Strong Buy
Analyst Count
23
2
Target Price
$20.02
$16.50
AVG Volume (30 Days)
6.4M
1.5M
Earning Date
05-07-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
27.43
N/A
EPS
N/A
N/A
Revenue
$67,671,000.00
$320,635,000.00
Revenue This Year
N/A
$17.45
Revenue Next Year
$62.75
$38.19
P/E Ratio
N/A
N/A
Revenue Growth
16.92
N/A
52 Week Low
$7.95
$5.97
52 Week High
$28.24
$20.85

Technical Indicators

Market Signals
Indicator
NTLA
TH
Relative Strength Index (RSI) 59.46 47.78
Support Level $11.73 $15.95
Resistance Level $16.93 $18.83
Average True Range (ATR) 1.16 0.87
MACD 0.13 -0.32
Stochastic Oscillator 56.30 25.51

Price Performance

Historical Comparison
NTLA
TH

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

Share on Social Networks: